Therefore, these results indicate that upregulation of LY6G6D and CD15/FUT4 can be efficiently abolished using a combination of JAK/STAT and MEK inhibitors in poorly immunogenic CRC subset. The gene discussed is FUT4; the disease is colorectal carcinoma.